Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (211)	1/16/2003 11:52:50 AM
From: tuck	Respond to of 3722

Hmmm. Seems to me AGEN's already filled that down gap and failed there. Further, it seems to be in a down trend after its recent foray above $12. Lower highs after that. Try it on the 30 minute instead for a clearer look at that filled gap. My target is low $10s. I went short some calls at $11 this morning, with the idea of stopping out in the $11.25 area. I guess they figure financing will remain tough, and selling at the middle of their yearly range is reasonable. I don't foresee much news between now and February expiration except the pricing of the offering. As such, I think it trades on TA till then, and with the markets, which look about done with their January effect rally to me. Cheers, Tuck